Qube Research & Technologies LTD Amneal Pharmaceuticals, Inc. Transaction History

Qube Research & Technologies LTD

$93.8 Billion
Q2 2025

A detailed history of Qube Research & Technologies LTD transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 1,910,862 shares of AMRX stock, worth $21.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,910,862

Previous 1,765,965 8.2%

Holding current value

$21.6 Million

Previous $14.8 Million 4.46%

% of portfolio

0.02%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$6.97 - $8.23 $1.01 Million - $1.19 Million	144,897 Added 8.2%	1,910,862 $15.5 Million
Q1 2025 May 15, 2025	BUY	$7.72 - $9.01 $3.61 Million - $4.22 Million	467,959 Added 36.05%	1,765,965 $14.8 Million
Q4 2024 Feb 14, 2025	BUY	$7.69 - $9.25 $355,639 - $427,784	46,247 Added 3.69%	1,298,006 $10.3 Million
Q3 2024 Nov 14, 2024	BUY	$6.42 - $8.83 $3.92 Million - $5.39 Million	610,852 Added 95.31%	1,251,759 $10.4 Million
Q2 2024 Aug 14, 2024	BUY	$5.36 - $7.11 $804,176 - $1.07 Million	150,033 Added 30.56%	640,907 $4.07 Million
Q1 2024 May 14, 2024	BUY	$5.24 - $6.34 $2.46 Million - $2.98 Million	470,323 Added 2288.57%	490,874 $2.97 Million
Q4 2023 Feb 13, 2024	BUY	$3.36 - $6.21 $69,051 - $127,621	20,551 New	20,551 $124,000
Q1 2023 May 15, 2023	BUY	$1.27 - $2.7 $52,970 - $112,614	41,709 Added 132.17%	73,265 $101,000
Q4 2022 Feb 14, 2023	BUY	$1.96 - $2.61 $61,849 - $82,361	31,556 New	31,556 $62,000
Q3 2021 Nov 12, 2021	SELL	$4.31 - $5.64 $149,901 - $196,159	-34,780 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$5.12 - $6.82 $153,139 - $203,986	-29,910 Reduced 46.24%	34,780 $178,000
Q1 2021 May 14, 2021	BUY	$4.74 - $7.38 $306,630 - $477,412	64,690 New	64,690 $435,000
Q4 2020 Feb 16, 2021	SELL	$3.95 - $5.42 $98,165 - $134,697	-24,852 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$3.54 - $5.27 $356,591 - $530,857	-100,732 Reduced 80.21%	24,852 $96,000
Q2 2020 Aug 14, 2020	BUY	$2.87 - $5.46 $360,426 - $685,688	125,584 New	125,584 $598,000
Q1 2020 May 15, 2020	SELL	$2.46 - $5.35 $100,493 - $218,552	-40,851 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$2.65 - $5.56 $108,255 - $227,131	40,851 New	40,851 $197,000

Others Institutions Holding AMRX

# of Institutions

256

Shares Held

146M

Call Options Held

194K

Put Options Held

49.3K

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.71B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Amneal Pharmaceuticals, Inc. Transaction History